TrialPLoS medicine2022

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19.

David M Lowe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.